IBD Stock Summary and Trading Ideas (Inspire Corporate Bond ETF | ARCA:IBD)

Inspire Corporate Bond ETF (IBD) invests in the investment grade bonds of inspiring, biblically aligned large companies ($13B+ market cap) from the United States. IBD is managed according to biblically responsible investing standards seeking to create meaningful impact in the world and help investors align their investments to support biblical values. The Inspire Corporate Bond ETF seeks to replicate investment results that generally correspond, before fees and expenses, to the performance of the Inspire Corporate Bond Impact Equal Weight Index.

Inspire Corporate Bond ETF trades on the ARCA stock market under the symbol IBD.

As of December 12, 2025, IBD stock price declined to $24.17 with 38,651 million shares trading.

IBD has a beta of -0.04, meaning it tends to be less sensitive to market movements. IBD has a correlation of 0.03 to the broad based SPY ETF.

IBD has a market cap of $454.40 million. This is considered a Small Cap stock.

In the last 3 years, IBD traded as high as $25.49 and as low as $21.95.

IBD has underperformed the market in the last year with a price return of +4.9% while the SPY ETF gained +14.0%. IBD has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +0.6% and -0.6%, respectively, while the SPY returned +4.0% and -0.2%, respectively.

IBD support price is $24.05 and resistance is $24.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IBD shares will trade within this expected range on the day.